Clinical Trials

The Michigan Medicine Department of Radiation Oncology is a worldwide leader in cancer treatment and research. The novel research studies and clinical trials conducted by our faculty drives discovery and advances our cancer treatment delivery and effectiveness.

To learn more about the studies in Radiation Oncology listed below, please email Jody Sharp or phone 734-615-4909.

Questions about cancer treatment at Michigan Medicine can also be addressed at the Rogel Cancer Center AnswerLine: (800) 865-1125. To learn more about open clinical trials throughout the Michigan Medicine enterprise, search the Rogel Cancer Center's clinical trials directory. For Oncology-specific trials, go to the Rogel Cancer Center's Oncology Clinical Trials listing.

Highlights

Changing the way oropharyngeal cancer is treated

A trial published in 2010 showed that intensity-modulated chemoradiotherapy can be delivered in such a way as to minimize swallowing difficulty in patients being treated for oropharyngeal cancer. The trial found that this way of delivering therapy did not diminish the effectiveness the treatment. This way of delivering therapy has now become standard practice for treatment of this type of cancer.

Changing the way hepatocellular cancer is treated

Our physicians showed in a 2005 trial that hepatocellular cancer can be effectively treated with radiation. Using techniques for dose planning and conformal therapy that were new at the time, our clinicians were able to give high doses of radiation to the tumor which resulted in increased survival. Building on this trial, our physicians and others have continued to improve and refine the treatment of hepatocellular cancer with radiation.

Highlights

List of Trials

Metastases

Brain

Head & Neck

Breast

Lung/Thoracic

Liver/GI

Prostate/GU

GYN

Other

VA Trials

Brighton Center for Specialty Care Trials

Video

Tess and Reshma